Neutrophil-to-Lymphocyte Ratio Predicts Prognosis in Castration-Resistant Prostate Cancer Patients Who Received Cabazitaxel Chemotherapy

Table 2

Multivariate analysis of overall survival after the administration of cabazitaxel.

Multivariate analysis	HR	95% CI lower	95% CI upper	value
Visceral metastasis	0.52	0.16	1.61	0.260
PSA ≥ 150.3 or <150.3	1.45	0.49	4.20	0.497
NLR ≥ 3.83 or <3.83	3.01	1.06	8.49	0.030
Alb < 3.7 or ≥3.7	2.45	0.81	7.34	0.108
Age ≥ 71.4 or <71.4	3.10	1.11	8.63	0.029
DOC course ≥ 9 or <9	2.12	0.71	6.33	0.177
Lymph node metastasis	12.38	2.62	58.35	0.001
LDH ≥ 269 or <269	2.85	1.03	9.31	0.052
ALP ≥ 429 or <429	0.80	0.26	2.36	0.108